医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Skin Garden: Demand for Korean Brand Moisturizers Is Growing at Remarkable Rate in Tokyo

2015年09月24日 PM12:23
このエントリーをはてなブックマークに追加


 

TOKYO

Skin Garden (http://www.skingarden.jp/), a K-cosmetics shop located in the central area of the Korean wave shopping district in Shinjuku, Tokyo, announced that the sales of moisturizing products have increased remarkably.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150923006380/en/

Skin Garden, a K-cosmetics shop located in the central area of the Korean wave shopping district in  ...

Skin Garden, a K-cosmetics shop located in the central area of the Korean wave shopping district in Shinjuku, Tokyo (Photo: Business Wire)

This is because Japanese customers are queuing up for Korean brand moisturizers to care for their skin that has become dry due to change of the season.

“Recently, the sales of Skin Garden ‘Hydro-gel Eye Patch’ and ‘Soothing Moisture Gel,’ which are Skin Garden’s PB brands, and Korean cosmetics brands’ mask sheets and moisturizing skin care products have increased sharply,” said an insider of Skin Garden, a leading Hallyu cosmetics shop in Japan. “The technological power of Korean cosmetics providing rich nourishment and moisturizing effect at a reasonable price range must have been a key to capturing the heart of meticulous Japanese consumers.”

Offering a wide range of trendy items at reasonable prices, Skin Garden, a K-beauty select shop, is much loved by Japanese consumers.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150923006380/en/

CONTACT

Skin Garden
Youngun Park, +82 70-8768-7946
park98@skingarden.jp

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402
  • Bertin与Zymo Research宣布达成新的合作